Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rech

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Cell Reports|December 12, 2023
T cell-mediated curation and restructuring of tumor tissue coordinates an effective immune responseJohn W Hickey, Maximillian Haist, Nina Horowitz, et al.
The Journal of Animal Ecology|November 11, 2025
Large herbivores are linked to higher herbaceous plant diversity and functional redundancy across spatial scalesJonas Trepel, Joe Atkinson, Elizabeth le Roux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
The Journal of Clinical Investigation|June 5, 2019
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)Nune Markosyan, Jinyang Li, Yu H Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2019
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, et al.
Research Square|April 16, 2025
Pathomics Image Analysis of Tumor Infiltrating Lymphocytes (TILs) in Colon CancerYuwei Zhang, Shahira Abousamra, Mahmudul Hasan, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
The Journal of Clinical Investigation|September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumorsAdham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Cell Reports|December 12, 2023
T cell-mediated curation and restructuring of tumor tissue coordinates an effective immune responseJohn W Hickey, Maximillian Haist, Nina Horowitz, et al.
The Journal of Animal Ecology|November 11, 2025
Large herbivores are linked to higher herbaceous plant diversity and functional redundancy across spatial scalesJonas Trepel, Joe Atkinson, Elizabeth le Roux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancersErica L Carpenter, Rosemarie Mick, Andrew J Rech, et al.
The Journal of Clinical Investigation|June 5, 2019
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)Nune Markosyan, Jinyang Li, Yu H Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2019
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, et al.
Research Square|April 16, 2025
Pathomics Image Analysis of Tumor Infiltrating Lymphocytes (TILs) in Colon CancerYuwei Zhang, Shahira Abousamra, Mahmudul Hasan, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
The Journal of Clinical Investigation|September 17, 2024
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumorsAdham S Bear, Rebecca B Nadler, Mark H O'Hara, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Pageof 10